img.

html Page 1 of 31

Essential Drugs List for Uganda (EDLU) 2001

The National Drug Authority

© 2001 by The National Drug Authority

All parts of this publication may be reproduced in any form, provided due acknowledgement is given

Copies may be obtained from:

The Executive Secretary/Registrar

National Drug Authority
PO Box 23096, Kampala
Uganda
Tel: 255665 / 255628 / 347391/2
Fax: 255758
Email: nda@imul.com

Computer typeset in Arial Truetype

Printed and bound in Uganda by

Marianum Press, PO Box 11, Kisubi
M.V.2001. 2M. JC101/2001

ISBN 9970-719-00-9

Foreword
It is my pleasure to present this revised and updated Essential Drugs list for Uganda (EDLU) 2001 to
all prescribing and dispensing staff, and to other health professionals handling medicines in Uganda.

This 3rd edition of EDLU has been produced in order to take account of the various changes which
have taken place in therapeutic practice over the 5 year period since the last edition.

Essential drugs are those which satisfy the needs of the majority of the population and should
therefore always be available in adequate amounts and appropriate dose forms. EDLU lists those
essential drugs considered to be the most appropriate for use in the Uganda public health system. It is
also strongly recommended as a rational basis for private sector prescribing.

In order to ensure that the correct decision is taken on whether to include a particular item or not,
consideration must be made of a number of key criteria including:

Efficacy: the capacity of the medicine effectively to treat the diagnosed condition

Safety: the therapeutic index of the drug (ratio of treatment dose to toxic dose) and

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 2 of 31

the nature, frequency and severity of expected side-effects

Quality: compliance of the drug presentation with internationally accepted standards

of purity, composition, and consistency

Cost-effectiveness: considered in terms of available and effective alternative

medicines or dose-forms

Appropriateness: the overall suitability of the medicine within the local context
taking account of various factors including:

• Changing morbidity patterns

• Stability in storage
• Likely compliance with dose regime
• Development of resistance
• Type of dose form/method of administration
• Socio-economic factors

In preparing the new EDLU, these criteria have been carefully considered by the Committee on
Essential Drugs (CED), assisted as required by experts in the various medical specialities.

Drug lists by their very nature are subject to rapid obsolescence due to ever-changing therapeutic
requirements for the treatment of conditions found in Uganda. A good example of this is the
treatment of malaria which has had to be revised recently to take account of rapidly developing
resistance to previous first-line medication.

Thus the list should be subject to constant scrutiny and updated accordingly. This process is highly
dependent on the input of clinicians in the field who should therefore continuously assess the
appropriateness of the selected medicines for treating the conditions encountered. Clinicians are
encouraged to submit proposals for amendments to EDLU following the procedures given in the
Preface.

The EDLU is a guide for drug selection and level of distribution and is meant to be used together
with the National Standard Clinical Guidelines (NSCG) which give practical guidance on diagnosis
and appropriate therapeutic approaches. Both publications are also useful resource materials for
training in all aspects of rational drug use.

I wish to thank the Chairman and members of the National Drug Authority Committee on Essential
Drugs for the time and effort they have put into the production of this excellent and vital document.

It is my sincere hope that routine use of the EDLU in combination with the NSCG by all levels of
prescriber in their daily work will greatly assist in ensuring that patients receive optimum treatment
of their health problems at all times.

However this will only be possible if adequate quantities of the recommended drugs are constantly
available for utilisation at the appropriate level of health unit.

The Ministry of Health is therefore committed to improving accessibility to required essential drugs
through active implementation of the new National Drug Policy which aims inter alia at securing
adequate funding of essential drugs procurement and improved management of the drug supply
system at all levels.

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 3 of 31

Dr C W C B Kiyonga MP
Hon. Minister of Health

Preface and Acknowledgements

1. Background to EDLU 2001

The first and second editions of EDLU were produced in 1991 and 1996 respectively. As with these
previous editions which it now supersedes, this new EDLU 2001 is produced with the aim of
assisting in making accessible and affordable to the majority of the population those drugs which are
necessary for the prevention and treatment of common health problems in the country.

The EDLU lists those essential drugs considered to be most suitable for current use in Uganda. The
current WHO model list (11th revision December 1999) was used as a basis for EDLU and modified
to suit the requirements of Uganda according to the criteria given in the Foreword by the Honourable
Minister of Health, and taking into account available resources and currently applicable clinical
practice.

According to the National Drug Policy the EDLU is a ‘primary drug management tool at all levels of
the health system’ and is intended to ‘to strengthen and harmonise the essential drugs selection
process at national and district levels for both public and private sectors’. The EDLU should be used
‘as a basis for procurement, prescribing and dispensing in the public health system and its use
promoted in the private (profit and non-profit) sector’.

Thus it is important to stress that, although the list is designed primarily for public sector use, it is
equally appropriate for private sector prescribers who are strongly encouraged to select EDLU
drugs whenever possible. Numerous changes have been made to EDLU to bring it into line with
currently accepted therapeutic requirements. These are summarised on pages xix-xxvi.

2. Amendment of EDLU 2001

As stated in the Foreword, the EDLU will be subject to constant review and revision. All clinicians
should therefore fully familiarise themselves with the contents of the EDLU and continuously
evaluate its relevance and appropriateness to their daily work.

Proposals for amendments to EDLU, together with supporting arguments and any available relevant
literature, should be forwarded in writing to:

The Chairman
National Drug Authority Committee on Essential Drugs
PO Box 23096, Kampala
Tel: 255665 / 255628 / 347391 / 347392
Fax: 255758
Email nda@imul.com

According to the National Drug Policy, the EDLU is supposed to be revised at least every three
years, thus the next edition should be produced by 2004.

In the meantime, any proposals will be discussed by the Committee on Essential Drugs. Agreed
amendments to the list will be notified to all prescribers through Ministry of Health circulars as
appropriate.

3. Acknowledgements

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 4 of 31

Preparation of this vital publication would not have been possible without the dedication and hard
work of my fellow contributing members of the Committee on Essential Drugs who are listed on
pages xv-xvi and without the invaluable contributions of the key clinical specialists listed on page
xvii. I wish to express my sincere thanks to them all for their time and efforts.

I am also greatly indebted to the Chairman and Executive Secretary / Registrar of NDA for
facilitating the completion of this work through the provision of a most suitable and supportive
working environment and to the NDA Secretariat staff for their continuous technical and
administrative support.

Dr A Lukanga-Ndawula
MB ChB, FRCS(Ed)
Chairman, NDA Committee on Essential Drugs

Contributing Members of the NDA Committee on Essential

Drugs (CED)
1. Dr A Lukanga-Ndawula

Chief of Medical Services, Uganda Peoples Defence Forces (UPDF)

Chairman, Committee on Essential Drugs

2. Dr E Owino

Head, Dept. of Pharmacy, Makerere University

3. Dr G W Zirembuzi

Senior Consultant Paediatrician, Mulago Hospital, Kampala

4. Dr J G M Jagwe (ex officio)

Chairman, NDA

5. Prof G R Nzarubara

Surgeon, Dept. of Surgery, Mulago Hospital, Kampala

6. Dr C W Kadama

Private Medical Practitioner, Centenary Clinic, Kampala representing the Private Medical
Practitioners Association

7. Ms D A Kusemererwa

Senior Pharmacist, Joint Medical Store (JMS), Kampala

8. Dr E K Kanyesigye

Assistant Commissioner of Health Services (Clinical)

Ministry of Health, Kampala

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 5 of 31

9. Mr G K Sematiko

Senior Pharmacist, Mulago Hospital, Kampala

10. Dr B A Mpeka-Tusubira

Assistant Commissioner Clinical Services

Ministry of Health, Kampala

11. Dr S Ndyanabangi

Principal Medical Officer, Ministry of Health, Kampala

12. Mrs C Ntegyeka

Pharmacist, Dept. of Pharmacy, Makerere University

13. Dr J C Lule

Acting Executive Secretary / Registrar

National Drug Authority
Secretary, Committee on Essential Drugs

14. Mr C J Forshaw

Pharmaceutical Advisor, National Drug Authority

DANIDA/Uganda Health Sector Support Programme
Editor, EDLU

Contributing Clinical Specialists

1. Dr M Mungherera

Psychiatrist,
Butabika Hospital, Kampala

2. Prof T Clshoz

Professor of Anaesthesiology,
University Hospital, Mbarara

3. Associate Prof M Kawuma

Dept. of Ophthalmology,
Makerere Medical School, Mulago Hospital, Kampala

4. Dr J V B Tindimwebwa

Head, Dept. of Anaesthesia,

Makerere Medical School, Mulago Hospital, Kampala

5. Mr E K Naddumba

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 6 of 31

Head, Dept. of Orthopaedics,

Makerere Medical School, Mulago Hospital, Kampala

Presentation of Information
1. General

Drug names: the relevant International Non-proprietary Name (INN) or generic name are used
throughout the list. According to the National Drug Policy and Authority Statute 1993 sec 12 generic
names shall be used for prescribing and labelling (ie. including dispensing) of drugs, except where
no such generic or suitable alternative non-proprietary name exists.

Order of sections: drugs are arranged in alphabetical order by pharmacological / therapeutic groups
following the same basic arrangement as the WHO Model List of Essential Drugs with the addition
of two additional sections: 28: Ear, Nose and Oropharyngeal Preparations and 29: Drugs for
Neurosurgical Use.

2. Level of Use

For each item the lowest level of health care facility at which the item may be used is indicated as
shown in the table below. This designation is in line with the diagnostic and clinical skills expected
to be available at that level. In certain cases the use of an item is further restricted to facilities where
a specific type of clinical and/or diagnostic expertise is available, eg. certain ophthalmological
preparations. The in-charge of each level of Health Centre is given in parentheses.

HC1 = Health Centre 1 (Community Level)

HC2 = Health Centre 2 (Enrolled Comprehensive Nurse)
HC3 = Health Centre 3 (Clinical Officer)
HC4 = Health Centre 4 (Medical Officer)
H = Hospital
R = Restricted Use (ie. needs high level diagnostic/clinical skills only available in specialised
institutions, eg. Cancer Institute, National Psychiatric Hospital, etc.)
Ref = Referral Hospital

Notes:

1. Diagnostic facilities: Health facilities of levels HC3 and higher have different degrees of
laboratory diagnostic support facilities available.

2. Drug availability: all of the items listed for health centre levels up to and including H (Hospital)
level are expected to be available at all times from National Medical Stores. More specialised items
with an R (Restricted) or Ref (Referral) designation will be available from NMS only at the request
of the relevant institution. It is therefore important that accurate estimates for the annual
requirements for these items are made by the institutions concerned well in advance and the
information forwarded to NMS so that sufficient quantities of the required items may be procured
and held in stock.

Abbreviations and Units

BNF = British National Formulary
BP = British Pharmacopoeia

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 7 of 31

BPC = British Pharmaceutical Codex

Inf = infusion
IM = intramuscular
Inj = injection
IT = intrathecal
IU = international units
IV = intravenous
MU = Mega Unit = one million (1,000,000) units
PFR = powder for reconstitution
SC = subcutaneous
SR = slow-release

G = gram = 1,000 mg = 0.001 kg

mg = milligram = 1,000 µg
µg = microgram = 0.001mg

L = litre = 1,000 mL
mL = millilitre = 0.001 L

Summary of Main Changes in EDLU 2001

A. Additions

1.1 General anaesthetics and oxygen

propofol injection 10mg/mL IV R
1.2 Local anaesthetics
lignocaine spray 10% HC4
1.3 Preoperative and peri-operative medication
ephedrine hydrochloride injection 3mg/mL Ref
fentanyl injection 50µg/mL Ref
midazolam injection 2mg/mL Ref
2.3 Opioid analgesics
morphine oral solution 1mg/mL HC3
4.1 Antidotes (General)
charcoal activated tablet 250mg HC2
4.2 Antidotes (Specific)
sodium thiosulphate injection 250mg or 500mg/mL H
6.1.1 Intestinal anthelminthics
mebendazole tablet 500mg HC1
6.2.1 Penicillins
flucloxacillin oral susp (PFR) 125mg/5mL HC4
6.2.2 Other antibacterial drugs
ceftriaxone powder for inj 250mg IV/IM Ref
ciprofloxacin tablet 500mg HC3
6.2.4 Antituberculosis drugs

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 8 of 31

ethambutol + isoniazid tablet 400mg + 150mg HC4

6.3 Antifungal drugs
clotrimazole pessary 500mg HC4
6.4.1 Antiamoebic drugs
tinidazole tablet 500mg HC4
6.4.3 Antimalarial drugs
artemether injection 100mg IM HC4
artemether tablet 50mg HC4
sodium artesunate tablet 50mg HC4
6.4.4 Antitrypanosomal drugs (African trypanosomiasis)
nifurtimox tablet 30mg R
nifurtimox tablet 120mg R
nifurtimox tablet 250mg R
6.4.6 Drugs used in toxoplasmosis
clindamycin capsule 150mg HC4
pyrimethamine tablet 25mg HC4
10.1 Antianaemia drugs
ferrous sulphate + folic acid tab 60mg elem.iron + 400µg HC1
12.1 Antianginal drugs
atenolol tablet 100mg H
12.2 Antidysrhythmic drugs
atenolol tablet 100mg H
12.3 Antihypertensive drugs
nifedipine tablet 10mg H
nifedipine tablet 20mg SR H
12.4.2 Drugs used in vascular shock
hydrocortisone sod. succinate injection (PFR) 100mg IV/IM HC3
13.1 Topical antifungals
miconazole cream 2% H
13.2 Topical antiinfectives
potassium permanganate solution aq 1:10,000 (0.01%) HC4
silver sulphadiazine cream 1% HC3
13.3 Topical antiinflammatories and antipruritics
betamethasone cream or ointment 0.1% HC4
13.4 Keratoplastics and keratolytics
benzoyl peroxide lotion or cream 5% HC4
13.6 Pediculicide
malathion lotion aqueous 0.5% HC2
14.1 Ophthalmic diagnostic agents
rose bengal eye drops 1% HC4
17.1 Antacids and other antiulcer drugs
omeprazole tablet 20mg H
17.2 Antiemetics
cyclizine tablet 50mg Ref

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 9 of 31

cyclizine inj 50mg/mL IM/slow IV Ref

domperidone tablet 10mg H
domperidone suspension 5mg/5mL H
domperidone suppository 30mg H
17.4 Antispasmodics
propantheline tablet 15mg H
17.6 Laxatives
senna tablet 7.5mg HC2
17.7.2 Antidiarrhoeals
loperamide tablet or capsule 2mg H
18.1 Adrenal hormones & synthetic substitutes
dexamethasone tablet 4mg H
18.5 Insulins and other antidiabetic agents
isophane insulin injection 100 IU/mL SC HC4
19.1 Diagnostic agents
tuberculin PPD injection 100 IU/mL HC3
19.2 Sera and immunoglobulins
antirabies immunoglobulin, injection 200 IU/mL HC4
human IM/local infiltration
20. Muscle relaxants & cholinesterase inhibitors
atracurium besylate injection 10mg/mL Ref
21.1.1 Antiinfective + antiinflammatory agents
neomycin + betamethasone eye drops 0.5% + 0.1% HC4
22.1 Oxytocics
ergometrine + oxytocin injection 500µg + 5 IU/mL IM HC2
22.2 Antioxytocics
salbutamol injection 1mg/mL IV inf HC4
25.1 Antiasthmatic drugs
aminophylline tablet 100 mg HC3
cromoglycic acid inhaler 5mg/metered dose (for adults) HC4
salbutamol nebuliser solution 2.5mg/mL H
salbutamol nebuliser solution 5mg/mL H
25.2 Antitussive drug
codeine phosphate tablet 30mg HC4
27. Vitamins and minerals
ergocalciferol tablet or capsule 250µg Ref
pyridoxine tablet 50mg HC4
retinol (vitamin A) capsule (drops) 50,000 IU HC2
retinol (vitamin A) capsule (drops) 100,000 IU HC2
28.1 Ear preparations
betamethasone ear/eye drops 0.1% H
28.3 Oropharygeal preparations
povidone-iodine mouthwash/gargle 1% HC3
triamcinolone acetonide oral paste 0.1% H

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 10 of 31

B. Deletions

1.2 Local anaesthetics

lignocaine spray 5% Hosp
2.1 Non-opioids
acetylsalicylic acid tablet 75mg HC
3. Anti-allergics & drugs used in anaphylaxis
astemizole tablet 10mg Ref
4.1 Antidotes (General)
charcoal activated tablet 50mg HC
4.2 Antidotes (Specific)
ferric hexacyanoferrate powder Hosp
sodium thiosulphate injection 1.5G/50mL Hosp
5. Antiepileptics and anticonvulsants
phenobarbitone (phenobarbital) tablet 30mg HC
phenobarbitone tablet 60mg HC
6.1.1 Intestinal anthelminthics
mebendazole tablet 100mg HC
6.1.3 Antischistosomals
niridazole tablet 600mg Ref
6.2.1 Penicillins
ampicillin powder for syrup 125mg/5mL Hosp
ampicillin tablet or capsule 250mg Hosp
cloxacillin powder for syrup 125mg/5mL Hosp
6.2.2 Other antibacterial drugs
cephalexin tablet 250mg R
lincomycin capsule 500mg Ref
tetracycline tablet / capsule 250mg HC
6.2.4 Antituberculosis drugs
rifampicin tablet / capsule 150mg Ref
6.4.3 Antimalarial drugs
chloroquine injection 200mg base/5mL HC
primaquine tablet 15mg HC
pyrimethamine tablet 25mg Hosp
8.3 Hormones and antihormones
stilboestrol tablet 5mg R
12.1 Antiangina drugs
cinnarizine tablet 75mg Ref
propranolol tablet 40mg Hosp
12.3 Antihypertensive drugs
diazoxide injection 300mg/20mL Hosp
13.1 Topical antifungals
griseofulvin tablet 250mg, 500mg Hosp
13.4 Astringent drugs
aluminium diacetate solution 13% Hosp

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 11 of 31

14.1 Ophthalmic diagnostic agents

homatropine eye drops 1% Hosp
17.2 Antiemetics
chlorpromazine tablet 25mg HC
chlorpromazine injection 25mg/mL deep IM Hosp
chlorpromazine suppository 100mg Hosp
prochlorperazine suppository 5mg HC
prochlorperazine suppository 25mg HC
17.4 Anti-inflammatory drug
sulfasalazine tablet 500mg R
17.5 Antispasmodic drugs
atropine injection 1mg/mL Hosp
hyoscine butylbromide tablet 10mg Hosp
18.1 Adrenal hormones and synthetic substitutes
vasopressin spray 10µg/dose Ref
vasopressin injection 5 IU Ref
18.7 Progestogens
medroxyprogesterone acetate injection 50mg/mL HC
19.1 Diagnostic agents
tuberculin, PPD with Tween 80 injection 5 IU/0.1mL HC
tuberculin, PPD with Tween 80 injection 5 IU/mL HC
19.2 Sera and immunoglobulins
antirabies immunoglobulin, injection 1,000 IU Hosp
human IM/local infiltration
19.3.2 Vaccines for specific groups of individuals
cholera vaccine inj 10mL/vial, 1.5mL/vial Hosp
21.1.1 Antiinfective + antiinflammatory agents
neomycin + beclomethasone eye drops 0.5% + 0.1% R
25.1 Antiasthmatic drugs
aminophylline tablet 200 mg HC
cromoglycic acid inhaler 1mg/dose Ref
25.2 Antitussive drug
codeine phosphate tablet 10mg Hosp
26.2 Parenterals
glucose infusion 10% HC
26.3 Miscellaneous
water for injection injection 100mL HC
27. Vitamins and minerals
calciferol injection 10,000 IU Hosp
pyridoxine tablet 25mg Hosp
vitamin B+C (Parenterovite) injection 5mL Ref
yeast dried tablet 300mg HC
28.1 Ear preparations
boric acid in spirit ear drops 1:16 (6.25%) H

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 12 of 31

chloramphenicol ear drops 0.5% H

hydrogen peroxide solution 3% H
ichthammol in glycerol ear drops 10% H
oxytetracycline + polymyxin B ear drops 0.5% + 0.119% H
salicylic acid ear drops 2% H
salicylic acid ear drops 10% H
28.2 Nasal preparations
cromoglycic acid nasal spray 2% Hosp
ephedrine nasal drops 0.5% HC
28.3 Oropharygeal preparations
alkaline phenol mouth wash solution HC
alkaline phenol gargle solution 1% HC
28.4 Miscellaneous
chromic acid solution 25% Ref
silver nitrate solution 0.5%-4% Hosp

ESSENTIAL DRUGS LIST FOR UGANDA

1. ANAESTHETICS

1.1 General anaesthetics and oxygen1

1Soda lime must be available for CO2 absorption during closed circuit general
anaesthesia

ether inhalation HC4

halothane inhalation HC4
ketamine injection 50mg/mL IV/IM HC4
ketamine injection paed 10mg/mL IV/IM HC4
nitrous oxide medical gas HC4
oxygen medical gas HC4
propofol injection 10mg/mL IV Ref
thiopental injection (PFR) 500mg IV HC4

1.2 Local anaesthetics

bupivacaine injection 0.25% IT/SC Ref

bupivacaine injection 0.5% IT/SC Ref
ethyl chloride spray HC3
lignocaine injection 2% (epidural) H
lignocaine dental cartridge 2% HC4
lignocaine injection 2% HC2
lignocaine spray 10% HC4
lignocaine paste 2-4% HC4

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 13 of 31

lignocaine ointment 5% HC4

lignocaine injection 5% (heavy spinal) H
lignocaine gel 2% HC3
lignocaine + epinephrine dental cartridge 2%+1:80 000 HC4

1.3 Preoperative and peri-operative medication

atropine injection 1mg/mL IV/IM HC4

diazepam rectal tube 2mg/mL HC2
droperidol injection 5mg/mL IV/IM/IVinf H
ephedrine hydrochloride injection 3mg/mL Ref
fentanyl injection 50µg/mL Ref
lorazepam injection 4mg/mL IV/IM H
midazolam injection 2mg/mL Ref
morphine injection 15mg/mL IV/IM/SC HC4

2. ANALGESICS, ANTIPYRETICS

2.1 Non-opioids

acetylsalicylic acid tablet 300mg HC1

diclofenac tablet 25mg HC4
diclofenac injection 25mg/mL IV/IM H
ibuprofen tablet 200mg HC2
paracetamol tablet 500mg HC1
paracetamol suppository 100mg HC3

2.2 Drugs used for gout

allopurinol tablet 100mg HC4

colchicine tablet 500µg HC4
indomethacin tablet 25mg HC4
probenecid tablet 500mg HC4

2.3 Opioid analgesics

codeine tablet 30mg HC4

dihydrocodeine tablet 30mg HC4
morphine injection 15mg/mL IV/IM/SC HC4
morphine oral solution 1mg/mL HC3
morphine tablet 30mg HC4
morphine tablet SR 10mg HC3
morphine tablet SR 30mg HC3
morphine tablet SR 60mg HC3
papaveretum + hyoscine injection 15.4mg + 0.4mg Ref
pethidine tablet 50mg HC4

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 14 of 31

pethidine injection 50mg/mL IV/IM/SC HC3

3. ANTI-ALLERGICS & DRUGS USED IN ANAPHYLAXIS

chlorphenamine tablet 4mg HC2

cyproheptadine tablet 4mg H
cyproheptadine syrup 2mg/5mL H
dexamethasone injection 4mg/mL IV/IM HC4
epinephrine (adrenaline) injection 1mg/mL IV/IM/SC HC2
hydrocortisone sod. succinate injection (PFR) 100mg IV/IM HC3
prednisolone tablet 5mg HC4
promethazine tablet 25mg HC2
promethazine injection 25mg/mL slow IV/IM HC4

4. ANTIDOTES

4.1 General

charcoal activated tablet 250mg HC2

ipecacuanha syrup 0.14% HC2
pralidoxime injection 200mg/mL IV/IM HC4

4.2 Specific

atropine injection 1mg/mL IV/IM HC4

benztropine injection 1mg/mL IV/IM HC4
calcium folinate (folinic acid) tablet 15mg Ref
calcium folinate (folinic acid) injection 3mg/mL IV/IM Ref
deferoxamine injection (PFR) 500mg IV H
dimercaprol injection 50mg/mL IM H
methionine tablet 250mg H
methylthioninium chloride (methylene blue) injection 10mg/mL IV H
naloxone injection 400µg/mL IV/IM/SC HC4
naloxone inj paed 20µg/mL IV/IM/SC HC4
penicillamine tablet 250mg H
sodium calcium edetate injection 200mg/mL IV H
sodium nitrite injection 30mg/mL IV H
sodium thiosulphate inj 250mg/mL or 500mg/mL IV H

5. ANTIEPILEPTICS AND ANTICONVULSANTS

carbamazepine tablet 200mg HC4

carbamazepine syrup 100mg/5mL HC4
clonazepam tablet 2mg Ref
clonazepam injection 500mg/mL IV Ref
diazepam injection 5mg/mL IV HC4

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 15 of 31

diazepam rectal tube 2mg/mL HC2

ethosuximide tablet 250mg H
ethosuximide syrup 250mg/5mL H
magnesium sulphate (specifically for convulsions in eclampsia) injection 500mg/mL (50%) IV HC3
phenobarbitone (phenobarbital) injection 200mg/mL IV/IM Ref
phenytoin injection 10mg/mL IV Ref
phenytoin tablet or capsule 50mg HC3
phenytoin tablet or capsule 100mg HC3
phenytoin suspension 30mg/5mL HC3
valproic acid tablet 200mg Ref

6. ANTI-INFECTIVE DRUGS

6.1 Anthelmintics

6.1.1 Intestinal anthelminthics

mebendazole tablet 500mg HC1

niclosamide tablet 500mg HC4

6.1.2 Antifilarials

diethylcarbamazine tablet 50mg H

ivermectin tablet 6mg HC3

6.1.3 Antischistosomals

praziquantel tablet 600mg HC3

6.2 Antibacterials

6.2.1 Beta Lactam Drugs

amoxicillin tablet or capsule 250mg HC2

amoxicillin tablet or capsule 500mg HC2
amoxicillin inj (PFR) 500mg IV/IM/IVinf HC4
amoxicillin syrup (PFR) 125mg/5mL HC2
amoxicillin + clavulanic acid tablet 250mg + 125mg Ref
ampicillin inj (PFR) 500mg IV/IM/IVinf HC4
benzathine benzylpenicillin injection (PFR) 2.4 MU IM HC3
benzylpenicillin inj (PFR) 1MU (600mg) IM HC2
ceftriaxone injection (PFR) 250mg IV/IM Ref
cefuroxime axitel tablet 250mg Ref
cefuroxime sodium injection (PFR) 750mg IV/IM Ref
cefuroxime oral susp (PFR) 125mg/5mL Ref
cloxacillin injection (PFR) 500mg IV/IM HC4
flucloxacillin capsule 250mg HC4

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 16 of 31

flucloxacillin syrup (PFR) 125mg/5mL HC4

phenoxymethylpenicillin tablet 250mg (Pen V) HC2
procaine benzylpenicillin forte injection (PFR) 4 MU IM (PPF) HC3

6.2.2 Other antibacterial drugs

chloramphenicol injection (PFR) 1G IV/IM HC3

chloramphenicol capsule 250 mg HC4
ciprofloxacin tablet 250mg HC3
ciprofloxacin tablet 500mg HC3
cotrimoxazole tablet 120mg HC2
cotrimoxazole tablet 480mg HC2
cotrimoxazole syrup 240mg/5mL HC2
doxycycline tablet 100mg HC2
erythromycin oral susp (PFR) 125mg/5mL HC4
erythromycin tablet 250mg HC2
gentamicin injection 40mg/mL IV/IM HC4
metronidazole infusion 5mg/mL H
metronidazole tablet 200mg HC2
nalidixic acid tablet or capsule 500mg H
nitrofurantoin tablet 100mg HC2

6.2.3 Antileprosy drugs1

1 may be available at designated health centres

clofazimine capsule 100mg R

dapsone tablet 100mg R
rifampicin2 tablet or capsule 150mg R
thalidomide tablet 50mg R

6.2.4 Antituberculosis drugs

ethambutol tablet 400mg HC4

ethambutol + isoniazid tablet 400mg+150mg HC4
isoniazid tablet 100mg HC4
pyrazinamide tablet 500mg HC4
2
rifampicin + isoniazid tab or cap 150mg+100mg HC4
rifampicin + isoniazid2 tab or cap 300mg+150mg HC4
rifampicin + isoniazid2 syrup 100mg+50mg/5mL HC4
streptomycin injection (PFR) 1G deep IM HC4

2 rifampicin products are reserved for TB/Leprosy Programme use only

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 17 of 31

6.3 Antifungal drugs

amphotericin B inj (PFR) 50mg for IV inf Ref

clotrimazole pessary 500mg HC4
fluconazole tablet or capsule 50mg Ref
fluconazole tablet or capsule 100mg Ref
fluconazole tablet or capsule 200mg Ref
flucytosine injection 10mg/mL for IV inf Ref
griseofulvin tablet 125mg HC3
griseofulvin tablet 500mg HC3
ketoconazole oral susp 100mg/5mL HC3
ketoconazole tablet 200mg HC3
miconazole pessary 100mg HC4
nystatin pessary 100,000 IU HC3
nystatin oral susp 100,000 IU/mL HC2
nystatin tablet 500,000 IU HC3

6.4 Antiprotozoal drugs

6.4.1 Antiamoebic drugs

metronidazole tablet 200mg HC2

tinidazole tablet 500mg HC4

6.4.2 Antileishmaniasis drugs

pentamidine isethionate inj (PFR) 200mg deep IM HC4

sodium stibogluconate inj 100mg/mL antimony IV/IM R

6.4.3 Antimalarial drugs

amodiaquine tablet 200mg HC3

artemether injection 100mg IM HC4
artemether tablet 50mg HC4
chloroquine inj 40mg base/mL IM/SC HC2
chloroquine tablet 150mg base HC1
chloroquine syrup 75mg base/5mL HC1
primaquine tablet 7.5mg HC4
proguanil tablet 100mg HC4
quinine inj 300mg/mL IV/deep IM HC3
quinine tablet 300mg HC4
quinine mixture 100mg/5mL HC4
sodium artesunate tablet 50mg HC4
sulfadoxine + pyrimethamine tablet 500mg + 25mg (SP) HC1

6.4.4 Antitrypanosomal drugs (African trypanosomiasis)

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 18 of 31

melarsoprol injection 36mg/mL slow IV HC4

nifurtimox tablet 30mg R
nifurtimox tablet 120mg R
nifurtimox tablet 250mg R
pentamidine isethionate inj (PFR) 200mg deep IM HC4
suramin sodium injection (PFR) 1G slow IV HC4

6.4.5 Antitrichomoniasis drugs

tinidazole tablet 500mg HC4

6.4.6 Drugs used in toxoplasmosis

clindamycin capsule 150mg HC4

pyrimethamine tablet 25mg HC4

6.5 Antiviral drugs

aciclovir tablet 200mg HC4

aciclovir tablet 400mg HC4
ganciclovir sodium injection (PFR) 500mG IV inf (for cytomegalovirus infection) R

7. ANTIMIGRAINE DRUGS

7.1 Treatment of Acute Attacks

acetylsalicylic acid tablet 300mg HC1

ergotamine tablet 1mg HC4
paracetamol tablet 500mg HC1

7.2 Prophylaxis

propranolol tablet 10mg HC4

propranolol tablet 20mg HC4

8. ANTINEOPLASTIC & IMMUNOSUPPRESSIVE DRUGS

8.1 Immunosuppressive drugs

azathioprine tablet 50mg R

8.2 Cytotoxic drugs

asparaginase (colaspase) injection (PFR) 100mg Ref

calcium folinate (folinic acid) tablet 15mg Ref
calcium folinate (folinic acid) injection 3mg/mL IV/IM/IVinf Ref
cyclophosphamide injection (PFR) 500mg IV Ref

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 19 of 31

cyclophosphamide tablet 50mg Ref

cytarabine inj (PFR) 100mg SC/IV/IT Ref
dacarbazine injection (PFR) 100mg IV Ref
dactinomycin injection (PFR) 500µg IV Ref
daunorubicin injection (PFR) 50mg IVinf Ref
doxorubicin (adriamycin) injection (PFR) 50mg IVinf Ref
fluorouracil injection 500mg/10mL IV R
hydroxyurea capsule 500mg R
mercaptopurine tablet 50mg R
methotrexate tablet 2.5mg R
methotrexate injection 50mg/mL IV/IM/IT Ref
mustine injection (PFR) 10mg IVinf R
procarbazine capsule 50mg R
stilboestrol tablet 5mg R
thioguanine tablet 40mg R
vincristine injection (PFR) 1mg IV R
vincristine injection (PFR) 5mg IV R

8.3 Hormones and antihormones

dexamethasone tablet 4mg HC4

dexamethasone inj 4mg/mL IM/slow IV/IVinf HC4
prednisolone tablet 5mg HC4
tamoxifen tablet 10mg HC4

9. ANTI-PARKINSONISM DRUGS

benzhexol tablet 2mg HC4

benztropine injection 1mg/mL IV/IM HC4
levodopa + carbidopa tablet 100mg + 10mg Ref
levodopa + carbidopa tablet 250mg + 25mg Ref

10. DRUGS AFFECTING THE BLOOD

10.1 Antianaemia drugs

ferrous salt tablet 60mg elemental iron HC1

ferrous sulphate oral solution paediatric BP HC2
12mg elemental iron/5mL
ferrous sulphate + folic acid tab 60mg elem.iron + 400µg HC1
folic acid tablet 1mg HC2
folic acid tablet 5mg HC2
hydroxocobalamin injection 1mg/mL IM HC4

10.2 Anticoagulants and antagonists

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 20 of 31

heparin injection 5,000 IU IV HC4

phytomenadione injection 1mg/mL IM HC4
phytomenadione injection 10mg/mL IM HC4
protamine sulphate injection 10mg/mL slow IV HC4
warfarin tablet 1mg HC4
warfarin tablet 3mg HC4

10.3 Fibrinolytic Agents

streptokinase injection 250,000 IU slow IV R

11. BLOOD PRODUCTS & PLASMA SUBSTITUTES

11.1 Plasma expanders

dextran 70 infusion IV 6% HC4

polygeline solution infusion IV 3.5% HC4

11.2 Plasma extracts

factor IX complex concentrate injection freeze-dried IV R

factor VIII concentrate injection freeze-dried IV R
albumin, human injection freeze-dried 25% IV R

12. CARDIOVASCULAR DRUGS

12.1 Antianginal drugs

atenolol tablet 100mg H

glyceryl trinitrate tablet sublingual 500µg H
glyceryl trinitrate patch 200µg H
isosorbide dinitrate tablet sublingual 5mg H
nifedipine tablet 10mg H

12.2 Antidysrhythmic drugs

atenolol tablet 100mg H

lignocaine inj 20mg/mL (2%) slow IV/IVinf Ref
procainamide tablet 250mg Ref
propranolol injection 1mg/mL slow IV Ref
propranolol tablet 40mg H
quinidine tablet 200mg Ref
verapamil tablet 40mg Ref

12.3 Antihypertensive drugs

atenolol tablet 100mg H

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 21 of 31

captopril tablet 25mg H

hydralazine tablet 25mg H
hydralazine tablet 50mg H
hydralazine injection 20mg/mL slow IV/IVinf H
methyldopa tablet 250mg HC4
nifedipine tablet 10mg H
nifedipine tablet 20mg SR H
propranolol tablet 40mg HC4
propranolol tablet 80mg HC4

12.4 Drugs used in heart failure

12.4.1 Cardiac glycosides

digoxin tab paed 62.5µg (0.0625mg) HC4

digoxin tablet 250µg (0.25mg) HC4
digoxin injection 250µg/mL IV HC4

12.4.2 Drugs used in vascular shock

dopamine injection 40mg/mL IVinf H

epinephrine (adrenaline) injection 1mg/mL IC/IVinf HC4
hydrocortisone sod. succinate injection (PFR) 100mg IV/IM HC3

13. DERMATOLOGICAL DRUGS

13.1 Topical antifungals

benzoic acid + salicylic acid ointment 6% + 3% HC2

clotrimazole cream 1% HC3
miconazole cream 2% H
nystatin cream or oint 100,000 IU/g HC3
sulphur + salicylic acid cream or oint 2% + 2% Hosp

13.2 Topical antiinfectives

acetic acid solution 10% H

chlorhexidine cream 5% HC4
framycetin impregnated gauze 1% HC3
iodine tincture 2% HC1
methylrosanilinium chloride aqueous paint 1% HC1
(gentian violet)
neomycin + bacitracin ointment 5mg + 500IU/g H
potassium permanganate solution aq 1:10,000 (0.01%) HC4
silver sulphadiazine cream 1% HC3

13.3 Topical antiinflammatories and antipruritics

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 22 of 31

betamethasone cream or ointment 0.1% HC4

calamine lotion 15% HC1
hydrocortisone cream or ointment 1% HC3

13.4 Keratoplastics and keratolytics

benzoyl peroxide lotion or cream 5% HC4

coal tar ointment 1% H
dithranol ointment 0.1% H
podophyllum resin paint 15% HC4
salicylic acid ointment 2% HC2
salicylic acid ointment 5% HC2

13.5 Scabicide

benzyl benzoate lotion 25% HC2

13.6 Pediculicide

malathion lotion aqueous 0.5% HC2

13.7 Other topical preparations

silver nitrate stick 40% HC3

14. DIAGNOSTIC AGENTS

14.1 Ophthalmic diagnostic agents1

1 for use only where ophthalmological expertise is available

fluorescein eye drops 1% HC4

physostigmine eye drops 0.25% HC4
rose bengal eye drops 1% HC4

14.2 Radiocontrast media

barium sulphate powder in water 75% w/v or more H

diatrizoate injection 60% H
diatrizoate injection 76% H
iodised oil fluid injection 38% H
ioglycamate injection 17% H
ioglycamate injection 35% H
iohexol injection 18% H
iohexol injection 24% H
iohexol injection 30% H

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 23 of 31

iohexol injection 35% H

iopanoic acid tablet 500mg H
iothalamate injection 54% H
iothalamate injection 60% H
iothalamate injection 70% H

15. DISINFECTANTS and ANTISEPTICS

15.1 Antiseptics

cetrimide + chlorhexidine solution 0.5% + 0.05% HC2

chlorhexidine gluconate solution 20% HC2
hydrogen peroxide solution 6% HC2
povidone iodine solution 10% HC3

15.2 Disinfectants

calcium or sodium hypochlorite solution 5% HC1

glutaraldehyde solution 2% H

16. DIURETICS

bendrofluazide tablet 5mg HC3

furosemide inj 10mg/mL IM/slow IV/IVinf HC4
furosemide tablet 40mg HC4
mannitol injectable sol. 20% IVinf H
spironolactone tablet 50mg HC4

17. GASTROINTESTINAL DRUGS

17.1 Antacids and other antiulcer drugs

bismuth chelate tablet 120mg Ref

cimetidine tablet 400mg HC4
magnesium trisilicate co. Tablet 370mg HC1
omeprazole tablet 20mg H
ranitidine tablet 150mg H

17.2 Antiemetics

cyclizine tablet 50mg Ref

cyclizine inj 50mg/mL IM/slow IV Ref
domperidone tablet 10mg H
domperidone suspension 5mg/5mL H
domperidone suppository 30mg H
prochlorperazine tablet 5mg HC3

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 24 of 31

prochlorperazine injection 12.5mg/mL deep IM HC4

promethazine tablet 25mg HC2
promethazine injection 25mg/mL deep IM HC3
metoclopramide tablet 10mg HC3
metoclopramide injection 5mg/mL HC4

17.3 Antihaemorrhoidals

bismuth subgallate compound suppository HC3

17.4 Antispasmodics

hyoscine butylbromide injection 20mg/mL Ref

propantheline tablet 15mg H

17.5 Laxatives

bisacodyl tablet 5mg HC4

bisacodyl suppository paediatric 5mg HC4
senna tablet 7.5mg HC2

17.6 Drugs used in diarrhoea

17.6.1 For oral rehydration

oral rehydration salts powder for 1L (WHO citrate formula) HC1

17.6.2 Antidiarrhoeals1

1 for symptomatic treatment of adults only

codeine phosphate tablet 30mg HC4

loperamide tablet or capsule 2mg H

18. HORMONES, OTHER ENDOCRINE DRUGS & CONTRACEPTIVES

18.1 Adrenal hormones & synthetic substitutes

ACTH (corticotrophin) injection 20IU/mL IM Ref

betamethasone tablet 0.5mg Ref
cortisone tablet 12.5mg Ref
cortisone tablet 25mg Ref
dexamethasone tablet 4mg H
dexamethasone inj 4mg/mL IM/slow IV/Ivinf H
hydrocortisone sod succinate inj 100mg IM/slow IV/Ivinf HC3
prednisolone tablet 5mg HC4

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 25 of 31

18.2 Androgens

methyltestosterone tablet 5mg Ref

testosterone enanthate inj oily 250mg/mL slow IM Ref

18.3 Hormonal contraceptives

ethinylestradiol + levonorgestrel tablet 30µg +150µg HC2

ethinylestradiol + levonorgestrel tablet 30µg +300µg HC2
ethinylestradiol + levonorgestrel tablet 50µg +250µg HC2
ethinylestradiol + norethisterone tablet 50µg + 1mg HC2
medroxyprogesterone acetate depot inj 150mg/mL deep IM HC3
levonorgestrel implant capsules 38mg/cap H
norgestrel tablet 75µg HC2

18.4 Oestrogens

stilboestrol tablet 1mg Ref

stilboestrol tablet 5mg Ref

18.5 Insulins and other antidiabetic agents

glibenclamide tablet 5 mg HC4

insulin soluble inj 40 IU/mL or 100 IU/mL SC1 HC4
insulin zinc suspension (lente) inj 40 IU/mL or 100 IU/mL SC1 HC4
isophane insulin injection 100 IU/mL SC HC4
metformin tablet 500mg Ref
metformin tablet 850mg Ref
tolbutamide tablet 500 mg HC4

1 The 40IU/mL strength is to be phased out

18.6 Ovulation inducers

bromocriptine tablet 2.5mg Ref

clomifene tablet 50mg Ref

18.7 Progestogens

norethisterone tablet 5 mg H

18.8 Thyroid hormones and antithyroid drugs

carbimazole tablet 5mg H

levothyroxine tablet 100µg HC4
iodine + potassium iodide oral solution 5% + 10% (Lugol’s iodine) HC4

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 26 of 31

19. IMMUNOLOGICALS<sup>2</sup>
2 See individual product literature for more information

19.1 Immunological diagnostic agents

tuberculin PPD injection 100 IU/mL HC3

19.2 Sera and immunoglobulins

anti-D immunoglobulin human injection 250µg/mL IM Ref

antirabies immunoglobulin, injection 200 IU/mL HC4
human IM/local infiltration
antirabies vaccine, human diploid injection IM/deep SC HC4
antiscorpion serum injection Ref
antitetanus immunoglobulin, human injection 500 IU IM Ref
antivenom sera polyvalent (East & Central Africa) injection IV HC4
diphtheria antitoxin injection 10,000 IU IM Ref
normal immunoglobulin, human injection 16% IM Ref

19.3 Vaccines

19.3.1 Vaccines for routine immunisation

BCG vaccine dried injection ID 20 dose vial HC2

diphtheria-pertussis-tetanus (DPT) injection IM/deep SC (20 dose vial) HC2
measles vaccine injection IM/deep SC (10 dose vial) HC2
poliomyelitis vaccine (live attenuated) oral solution 20 dose HC2
tetanus toxoid vaccine (20 dose vial) injection IM/deep SC HC2

19.3.2 Vaccines for specific groups of individuals

hepatitis B vaccine inj IM/deep SC single dose HC2

meningococcal vaccine A+C inj IM/deep SC single dose HC2
plague vaccine inj IM/deep SC single dose HC2
rabies vaccine human diploid inj IM/deep SC single dose HC2
rubella vaccine inj IM/deep SC single dose H
typhoid vaccine inj IM/deep SC single dose HC2
yellow fever vaccine inj SC single dose HC2

20. MUSCLE RELAXANTS & CHOLINESTERASE INHIBITORS

alcuronium chloride injection 5mg/mL IV Ref

atracurium besylate injection 10mg/mL Ref
edrophonium injection 10mg/mL IV H
neostigmine tablet 15mg HC4
neostigmine injection 500µg/mL IM/SC H

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 27 of 31

pancuronium bromide injection 2mg/mL IV Ref

suxamethonium injection 50mg/mL IV/IVinf HC4
tubocurarine injection 10mg/mL IV H

21. OPHTHALMOLOGICAL PREPARATIONS

21.1 Antiinfective agents

aciclovir eye ointment 3% Ref

chloramphenicol eye ointment 1% HC2
chloramphenicol eye drops 0.5% HC2
gentamicin eye/ear drops 0.3% HC4
idoxuridine eye drops 0.1% Ref
idoxuridine eye ointment 0.5% Ref
tetracycline eye ointment 1% HC1

21.1.1 Antiinfective + antiinflammatory agents1

1 for use only where qualified ophthalmological staff is available

neomycin + betamethasone eye drops 0.5% + 0.1% HC4

hydrocortisone + eye drops 1.5% + HC4
oxytetracyline + polymyxin B 0.5% + 0.119%

21.2 Antiinflammatory agents1

1 for use only where qualified ophthalmological staff is available

betamethasone eye drops 0.1% HC4

hydrocortisone eye drops 0.5% HC4
hydrocortisone eye ointment 1% HC4

21.3 Local anaesthetics1

1 for use only where qualified ophthalmological staff is available

tetracaine (amethocaine) eye drops 0.5% H

tetracaine (amethocaine) eye drops 1% H

21.4 Miotics and antiglaucoma drugs1

1 for use only where qualified ophthalmological staff is available

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 28 of 31

acetazolamide tablet 250mg HC4

pilocarpine eye drops 2% HC4
pilocarpine eye drops 4% HC4
timolol eye drops 0.25% Ref
timolol eye drops 0.5% Ref

21.5 Mydriatics1

1 For use only where ophthalmological expertise available

atropine eye drops 1% H

cyclopentolate eye drops 2% Ref
phenylephrine eye drops 10% HC

21.6 Astringents1

1 For use only where ophthalmological expertise available

zinc sulphate eye drops 0.25% HC4

22. OXYTOCICS & ANTI-OXYTOCICS

22.1 Oxytocics

ergometrine tablet 200µg HC4

ergometrine + oxytocin injection 500µg + 5 IU/mL IM HC2
methylergometrine inj 200µg/mL IM/slow IV HC2
oxytocin inj 10 IU/mL slow IV/inf H

22.2 Antioxytocics

salbutamol tablet 4mg HC3

salbutamol injection 1mg/mL IV inf HC4

23. PERITONEAL & HAEMODIALYSIS SOLUTIONS

electrolyte solutions for dialysis2 Ref

2 See product literature for details of presentation

24. PSYCHOTHERAPEUTIC DRUGS

amitriptyline tablet 25mg HC4

carbamazepine tablet 200mg HC4
chlordiazepoxide tablet 10mg HC4

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 29 of 31

chlordiazepoxide tablet 25mg HC4

chlorpromazine tablet 25mg HC2
chlorpromazine tablet 100mg HC2
chlorpromazine injection 25mg/mL deep IM HC2
diazepam inj 5mg/mL IM/slow IV/IVinf HC4
diazepam tablet 5mg HC4
fluphenazine decanoate inj oily 25mg/mL deep IM Ref
haloperidol tablet 5mg Ref
haloperidol tablet 10mg Ref
haloperidol injection 5mg/mL IM Ref
haloperidol decanoate inj oily 50mg/mL deep IM Ref
haloperidol decanoate inj oily 100mg/mL deep IM Ref
imipramine tablet 25mg HC4
lithium carbonate tablet 250mg Ref
lorazepam tablet 2mg Ref
nitrazepam tablet 5mg HC4
thioridazine tablet 25mg Ref
thioridazine tablet 100mg Ref
trifluoperazine tablet 5mg H
zuclopenthixol decanoate inj oily 200mg/mL deep IM R

25. DRUGS ACTING ON THE RESPIRATORY TRACT

25.1 Antiasthmatic drugs

aminophylline tablet 100 mg HC3

aminophylline inj 25mg/mL slow IV/IVinf HC4
beclomethasone inhaler 50µg/metered dose HC4
epinephrine (adrenaline) injection 1mg/mL SC HC2
salbutamol nebuliser solution 2.5mg/mL H
salbutamol nebuliser solution 5mg/mL H
salbutamol inhaler 100µg/metered dose HC4
salbutamol tablet 4mg HC3
sodium cromoglycate inhaler 5mg/metered dose for adults) HC4

25.2 Antitussive drug

codeine phosphate tablet 30mg (for adults) HC4

25.3 Cough soothing preparation

simple linctus syrup (BNF formula) HC2

26. SOLUTIONS CORRECTING WATER, ELECTROLYTE, & ACID-BASE

DISTURBANCES

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 30 of 31

26.1 For oral rehydration

oral rehydration salts powder for 1 L WHO citrate formula) HC1

26.2 Parenterals

calcium gluconate injection 100mg/mL (10%) HC1

Darrow’s solution infusion ½ strength in 2.5% HC2
glucose
glucose infusion 5% HC2
glucose infusion 50% HC3
potassium chloride inj 150mg/mL slow IV inf H
sodium bicarbonate injection 8.4% slow IV H
sodium chloride infusion 0.9% HC2
sodium lactate compound Hartmann’s or Ringer-Lactate infusion HC4
solution)

26.3 Miscellaneous

water for injection injection 2mL IV/IM HC2

water for injection injection 5mL IV/IM HC2
water for injection injection 10mL IV/IM HC2

27. VITAMINS & MINERALS

ascorbic acid (vitamin C) tablet 100mg HC3

calcium lactate tablet 300mg HC3
ergocalciferol (vitamin D2) tablet or capsule 250µg 10,000 IU) Ref
multivitamin tablet (BPC 73) HC1
nicotinamide tablet 50mg HC4
potassium chloride tablet 600mg SR H
pyridoxine (vitamin B6) tablet 50mg HC4
retinol (vitamin A) capsule (drops) 50,000 IU HC2
retinol (vitamin A) capsule (drops) 100,000 IU HC2
retinol (vitamin A) capsule (drops) 200,000 IU HC2
vitamin B complex injection IM1 HC4
vitamin B complex (strong) tablet (BPC 73) HC4

1Contains: nicotinamide 40mg, pyridoxine HCl 4mg, riboflavine 4mg, thiamine HCl
10mg/2mL amp

28. EAR, NOSE & OROPHARYNGEAL PREPARATIONS

28.1 Ear preparations

betamethasone ear/eye drops 0.1% H

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17
img.html Page 31 of 31

clotrimazole solution 1% H
gentamicin ear drops 0.3% H

28.2 Nasal preparations

beclomethasone nasal spray 50µg/metered dose H

ephedrine nasal drops 1% (for adults) H
lignocaine + adrenaline nasal drops 2% +1:100,000 Ref
xylometazoline nasal drops 0.05% HC4
xylometazoline nasal drops 0.1% HC4

28.3 Oropharygeal preparations

lidocaine (lignocaine) lozenges 4% HC4

lidocaine (lignocaine) spray 5% HC4
miconazole oral gel 2% HC4
povidone-iodine mouthwash/gargle 1% HC3
triamcinolone acetonide oral paste 0.1% H

29. DRUGS FOR NEUROSURGICAL USE

29.1 For cerebral metabolism/perfusion

piracetam tablet 800mg R

piracetam injection 125mg/mL IV/IM R

National Drug Authority

Secretariat Office, Plot 93 Buganda Road
PO Box 23096 Kampala
Tel: 255665/347391/347392 Fax: 255758
Email: nda@imul.com

file://J:\DivData\ALLDOCS\MoniqueRenevier\COUNTRYlists\Uganda\Uganda_200... 2007-05-17